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Digital multiplex ligation assay for highly
multiplexed screening of β-lactamase-encoding
genes in bacterial isolates
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Maria Camila Montealegre2 & Timothy R. Julian 2,4,5✉
Increasing incidence of antibiotic resistance in clinical and environmental settings calls for
increased scalability in their surveillance. Current screening technologies are limited by the
number of samples and genes that can easily be screened. We demonstrate here digital
multiplex ligation assay (dMLA) as a low-cost targeted genomic detection workflow capable
of highly-parallel screening of bacterial isolates for multiple target gene regions simulta-
neously. Here, dMLA is used for simultaneous detection of 1187 β-lactamase-encoding genes,
including extended spectrum β-lactamase (ESBL) genes, in 74 bacterial isolates. We
demonstrate dMLA as a light-weight and cost-efficient workflow which provides a highly
scalable tool for antimicrobial resistance surveillance and is also adaptable to genetic
screening applications beyond antibiotic resistance.
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Antibiotic resistant bacteria are a global threat to humanhealth, animal health and the environment1. β-lactamaseproducing antibiotic resistant bacteria are amongst the
most concerning since they confer resistance to essential
medicines2,3; and increase the likelihood of treatment failure and
mortality relative to susceptible infections4,5. In community set-
tings, carriage rates of extended-spectrum β-lactamase producing
Enterobacteriaceae (ESBL-E), an important subset of β-lactamase
producing antibiotic resistant bacteria, is increasing at particu-
larly alarming rates in low and middle income countries6,7.
Detailed antibiotic resistance gene (ARG) surveillance at
regional, national, and global scale is required for the develop-
ment of strategies aiming to mitigate this health threat. Current
methods include PCR, multiplexed PCR8, integrated PCR and
sequencing9, whole-genome sequencing9,10, SmartChip™ qPCR11
and targeted metagenomics12. High diversity of β-lactamase
ARGs13 impacts the applicability of the current methods for their
detection and classification, resulting in limited scalability and
relatively high per-sample costs. A scalable, low cost method is
therefore needed for specific detection of ARGs to aid
surveillance.
Here, we present a digital multiplex ligation assay (dMLA) for
simultaneous detection of 1187 β-lactamase-encoding genes
within 74 bacterial isolates. The assay integrates in silico probe
design with ligation-based genomic target detection and next-
generation DNA sequencing (NGS). Recently, a closely related
approach, digitalMLPA, was applied for the detection of copy
number alterations in T- and B-cell lymphoblastic leukaemia14
and multiple myeloma15. A closely related approach, TAC-seq,
was also recently introduced to improve the sensitivity of non-
invasive prenatal trisomy testing16. Our dMLA assay is readily
adaptable for detection of any number of ARGs and is equally
applicable for any other genomic targets beyond ARGs. High
scalability of dMLA in terms of sample throughput as well as
ARG targets allows unprecedented insights into ARG
epidemiology.
Results
dMLA combines ligation assays with NGS for high scalability.
In dMLA, two target specific half-probes (20 bp) are designed to
anneal to adjacent regions on a target gene sequence within the
extracted DNA of a bacterial isolate (Fig. 1a). Each of the
two half-probes (right and left) include an overhang with a PCR
binding sequence. The right overhang also includes a molecular
barcode between the PCR binding site and the target binding site,
which is used to differentiate between ligation events and act as a
proxy for individual DNA fragments in the original sample.
When left and right probes anneal, ligase is used to form a
phosphodiester bond in between, allowing subsequent PCR
amplification of the product. The PCR step simultaneously atta-
ches a sample barcode as an overhang on the left PCR primer
(Fig. 1b, c). Sample barcodes allow multiple samples to be pooled
for NGS, with differentiation after sequencing the pooled
amplicons (Fig. 1d). Probe sequencing data is transformed into
molecular target counts by enumerating the number of individual
molecular barcodes for each target using an in silico workflow
(Fig. 1e).
dMLA probe design utilizes in silico analysis for maximal
coverage. We prepared dMLA targets for 1187 of the
1557 β-lactamase genes in the Lahey dataset3. This subset was
selected by detecting the universally conserved sequence motifs
within the dataset using a BLAST-like algorithm17, and subse-
quently using a set coverage algorithm to identify those motifs
which cover 76 % of the set with 36 probes (Fig. 2, Table S1).
dMLA permits multiplexed detection of ARGs in a large
number of samples. We demonstrated the utility of dMLA using
genomic DNA isolated from representatives of common patho-
gens belonging to families Alcaligenaceae, Enterobacteriaceae,
Flavobacteriaceae, Moraxellaceae and Pseudomonadaceae. Within
74 bacterial isolates screened, dMLA detected 194 β-lactamase-
encoding genes with no false positives or negatives (Fig. 3, Sup-
plementary Fig. 1). In addition to the ESBL-encoding genes
detected and confirmed by PCR, intrinsic resistance genes that
were universally detected were the chromosomally encoded
AmpC-type β-lactamases blaADC, blaPDC, and blaMIR, detected in
all (and only) the 17 Acinetobacter baumannii, 12 Pseudomonas
aerugonisa, and one Enterobacter cloacae isolates, respectively, as
well as the chromosomally-encoded oxacillinase blaOXA-51-family in
all A. baumannii group isolates18–22. dMLA also detected the
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Fig. 1 dMLA probe setup. a Two adjacent half probes hybridized to target gene. Ligase connects the 3′ end of the left probe with the 5′ phosphorylated end
of the right probe and the resulting fragment is amplified by conventional PCR. Molecular barcodes permit quantifying the number of target molecules
while sample barcodes added during PCR permit pooling multiple samples on a single sequencing run. b Location of the molecular barcode sequences,
target binding site, and PCR primer sites on post-ligation probes. c Multiple ligated probes within a sample with unique molecular barcodes are then
amplified with PCR, which also attaches a unique sample barcode identifier. The primer binding sites are the same for all probes, so PCR amplifies any
probes that ligate in the presence of a target gene region. d PCR products of amplified, ligated probes are then pooled for sequencing. e Sequencing reads
are analyzed by the bioinformatics pipeline through sample and molecular barcodes.
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chromosomally-encoded blaSHV in all five Klebsiella pneumoniae
isolates23.
Discussion
Here, dMLA was specifically designed for highly parallel screen-
ing of bacterial isolates for β-lactamase-encoding genes within the
context of national, regional, or global surveillance programs.
Detection of intrinsic resistance genes highlights the specificity
achievable with the dMLA method. Notably, the combination of
the number of probe pairs and bacterial isolates demonstrated
here is not reflective of the upper limits of the assay. dMLA could
support substantially higher numbers of both probe pairs and/or
bacterial isolates, with limitations theoretically driven only by
sequencing depth. Additional probe pairs may be beneficial,
particularly to highlight clinical relevance. As an example, many
of the Acinetobacter baumannii-calcoaceticus-complex isolates
contained oxacillinases which were not covered by the 36 probe
pairs included in our assay (i.e., OXA-24, OXA-25, OXA-26,
OXA-91, OXA-143). Further optimization of dMLA will likely
improve assay sensitivity and reduce time of analysis and
associated costs.
The dMLA workflow shares common features with MLPA
assays24, for instance the concept of annealing of two probes for
subsequent ligation and multiplexed PCR. Recently, a combina-
tion of MLPA-like workflow with NGS has been used to screen
samples for cancer-specific markers14,15 and abnormal chromo-
somal markers in maternal blood16. Furthermore, conceptually
similar approaches demonstrate target quantification as well as
detection of single nucleotide polymorphisms14–16,25. Our
approach also shares similarity with network analysis, examples
of which have recently been used for degenerate primer design13,
and highlights the use of in silico design and/or evaluation of PCR
primers to improve target coverage and reduce laboratory work26.
dMLA may be designed to quantify target gene regions in a
sample and/or detect point mutations, for example gene muta-
tions associated with increased antibiotic resistance. However,
application of dMLA for reliable quantification will require
optimizing the assay to control for potential differences in unique
molecular counts attributable to factors beyond the number of
cells per assay. Example factors include variable numbers of target
genes per cell (chromosomal vs. plasmid gene targets) and vari-
able efficiencies in probe-target binding affinity, ligation, and
PCR amplification efficiency. The latter likely explain observed
variation in unique molecular barcode counts amongst distinct
probe pairs targeting the same gene within the same sample
(Fig. 3, Supplementary Fig. 1). One potential approach to expand
dMLA to quantification would be to incorporate standards within
the assay, such as those applied in qPCR assays.
Materials and methods
dMLA probe design. Probes for β-lactamase genes were designed to detect 18 β-
lactamase resistance gene cluster sequences covering 1187 of 1557 (76%) of the β-
lactamase genes in the Lahey dataset (accessed 26 July 2016)3. Two probe pairs
were designed for each cluster to permit two-fold verification of cluster presence.
To design probes, probe pair candidate sequences (40 bp) from all β-lactamase
genes were generated using a sliding window function in R Statistical Software (v
3.5.1) (code available at https://github.com/manutamminen/dmla/). The universal
set of 40-mers were used for a similarity search against all β-lactamase-encoding
genes (implemented in nsearch;17, and filtered using a set coverage algorithm
(implemented in epride, at https://github.com/manutamminen/epride) to select the
subset with maximum coverage of the Lahey sequence database (Supplementary
Fig. 1). A subset of clusters were chosen for dMLA, based on clinical relevance and/
or sequence coverage depth (Supplementary Fig. 1, Supplementary Table 1). The
probe pair candidates within each cluster were further filtered to identify sets with
shared annealing temperatures (<2 °C apart).
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Fig. 2 Network visualization of the dMLA probe coverage of the Lahey ESBL resistance gene dataset. The nodes indicate individual resistance gene
sequences and the edges at least one shared 40 bp sequence motif between them. The colours and coloured text indicate our probe designs, which cover
particular clusters within the β-lactamase sequence pool, while the open circles with red outline indicate sequences for which probes have not been
designed. The black texts indicate different β-lactamase clusters within the Lahey resistance gene dataset.
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dMLA probe testing and validation. Up to five candidate probe pairs per cluster
were tested in singleplex PCR with synthetic template DNA of the probe pair target
gene region (Microsynth AG, Balgach, Switzerland). Ligation proceeded in a Bio-
metra T3000 thermocycler set to 94 °C for 10 min followed by 60 °C at 90 min
using AmpLigase (5 units; Epicentre and Lucigen) and AmpLigase buffer, left and
right ligation probes (40 nM each, Table S1), and template (100 fM, 1 and 10 pM
for each probe pair) or a no template control (NTC) in a final volume of 25 µl. No-
ligase controls (NLC) were tested without template and using 10 pM templates.
Subsequent PCR (25 μl reaction) was performed by adding Phusion High-Fidelity
DNA Polymerase (2 units; BioLabs), Phusion buffer (1x), dNTPs (final con-
centration 0.2 mM), forward primer (with sample-specific barcode denoted here as
‘NNNNNNN’; 5′-TCTTTTCGCAGGCTGGAGCCCAGGTCTTCCTATNNNNN
NNTGGGCCCAATTTTCCGTGAC-3′, 400 nM), reverse primer (5′ - GAGTGCA
CGCACACTCATTC-3′, 400 nM) and ligation product (1 μl) or NTC (RNAse/
DNAse free water) into a final volume of 25 µl. Thermocycling conditions were
98 °C for 30 s followed by 35 cycles of 98 °C for 5 s, 70 °C for 1 s, and 72 °C for 3 s
with a final 72 °C for 5 min. PCR products (10 μl) were visualized in 1.5% agarose
gels in TAE Buffer using 0.01% SYBR SAFE (Thermo Scientific) on a Biorad
PowerPac 300 Gel Electrophoresis/Vilber E-Box VX-2 gel imager in comparison to
3 μl of 100 bp standard ladder (Promega). Probe pairs were deemed unsuccessful if
no band was visible at 140 bp or if a band was visible at 140 bp in the NTC or NLC.
Approximately half of all probe pairs tested were unsuccessful, with detection of a
band in the NLC as the most common cause.
The dMLA was tested with 74 bacterial isolates for 18 clusters using two probe
pairs for each cluster (Fig. 2). The bacterial isolates included 60 isolates hosting
known β-lactamase genes previously characterized by Patrice Nordmann’s lab
(University of Fribourg, Fribourg, Switzerland, personal communication) and 14
Escherichia coli isolates from Bangladesh27,28. The bacterial genomic DNA was
extracted by boiling at 100 °C for 1 h. Ligation and PCR proceeded as described,
with a probe pair mix totalling 1 μM, and 2 probe pairs per cluster for 18 clusters.
The PCR products were quantified using a Qubit dsDNA high sensitivity kit
(Invitrogen, CA, USA) and pooled based on concentration prior to Illumina MiSeq
sequencing (Eurofins) with 150 bp paired end reads, which was chosen to ensure
complete doubly confirmed coverage of the sequenced area (138 bp).
Sequence data analysis. Paired-end merging, quality filtering, and read mapping
of the FASTQ output data from Illumina HiSeq was performed using nsearch17.
Reads were then mapped to reference databases to identify associated β-lactamase-
encoding gene clusters and sample IDs (bacterial isolate). For each combination of
cluster and sample IDs, the unique molecular barcodes (Fig. 1a) were counted. The
detection limit was calculated based on experimental background noise estimated
from NTCs and/or susceptible bacterial isolates with no resistant genes. Sampling-
corrected signals exceeding the sum of the mean with three times the standard
deviation of the blank experiments in both replicates were considered reliable. The
sequence data (PRJNA531165) is available at SRA. For further detail, the workflow
is available online at https://github.com/manutamminen/dmla with the reference
data set and annotation available at: https://github.com/manutamminen/dmla/
blob/master/Allele-dna.fa and https://github.com/manutamminen/dmla/blob/
master/Allele.tab, respectively. β-lactamase-encoding genes identified using dMLA
AB_R16
AB_R27
AB_R277
AB_R701
AI_R864
AR_R1287
AX_R1281
Ab_R1144
Ab_R214
Ab_R432
Ab_R670
Ab_R695
Ab_R697
Ab_R700
Ab_R820
Ab_R836
Ab_R853
Ab_R860
Ac_R1409
Av_R1171
Ax_R1280
CI_R424
CI_R425
CI_R427
CI_R428
EC_OW10E2
EC_OW29E1
EC_OW38E1
EC_OW5E1
EC_R1288
EC_human1348
Ec_DSM22311
Ec_G432
Ec_R1033
Ec_R1294
Ec_R2219
Ec_R2220
Ec_R2221
Ec_R457
HH−08−CH
HH−13−CH
HH−13−H
HH−13−S
HH−15−C
HH−17−S
HH−19−CH
HH−19−H
HH−20−S
HH−26−H
HH−36−S
HH−41−S
HH−46−S
HH−50−S
KP_R2203
KP_R884
KP_S100
KP_S130
Kp_DSM16609
MM_G394
MM_G400
PA_G445
PA_G451
PA_R1298
PA_R1302
PA_R1308
PA_R2454
PA_R76
Pa_DSM102273
Pa_DSM102274
Pa_DSM24600
Pa_N16
Pa_R1301
Pm_G464
0
2500
5000
7500
10000
12500
Molecular
count
Intrinsic
resistance
1 2
AC
T/ 
MI
R
AD
C
CA
RB
CF
E/
CM
Y/
LA
T
CM
Y/
FO
X/
MO
X
CT
X−
M 
gro
up
 1
CT
X−
M 
gro
up
 2
CT
X−
M 
gro
up
 9
CT
X−
M 
gro
up
s 8
 an
d 2
5
GE
S
IM
P
OX
A−
21
3 f
am
ily
OX
A−
48
 fa
mi
ly
OX
A−
51
 fa
mi
ly
PD
C
SH
V
TE
M
VI
M
1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2
A
ci
ne
to
ba
ct
er
ba
um
an
ni
i -
 
ca
lc
oa
ce
tic
us
co
m
pl
ex
Acinetobacter radioresistens
Achromobacter xylosoxidans
Chryseobacterium indologenes
Es
ch
er
ic
hi
a 
co
li
Proteus mirabilis
Morganella morganii
Klebsiella pneumoniae
Ps
eu
do
m
on
as
ae
ru
gi
no
sa
Probe
pairs
Aeromonas veronii
Enterobacter cloacae
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that are not intrinsic resistance genes were confirmed using previously published
multiplexed PCR primers8.
Statistics and reproducibility. The dMLA detection limits were defined based on
false positive signals in triplicate, independently prepared blank samples. From
these triplicate samples, the mean and standard deviation of the number of unique
molecules arising as false positive signals were calculated for each probe target
independently. The detection limit was defined as the sum of the mean and three
times the standard deviation, equivalent to 99.7% of the distribution assuming it is
normally distributed. Any signal from the samples above this limit was considered
statistically significant, which was used to differentiate between detection and non-
detection.The analyses are available at https://github.com/manutamminen/dmla.
The data were replicated using two independent sequencing runs, one with 35
PCR cycles (presented here) and one with 40 PCR cycles. The detect/non-detect
classification was identical.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated during and/or analysed during the current study are available in
the following repositories. DNA sequencing data is available at Sequence Read Archive
(SRA; https://www.ncbi.nlm.nih.gov/sra) under accession PRJNA531165. β-lactamase
sequences, their metadata and the probe designs are available at https://github.com/
manutamminen/dmla.
Code availability
All source code for preparing the dMLA probes, processing the DNA sequencing data,
visualizing the results and performing the statistical tests is publicly available at https://
github.com/manutamminen/dmla.
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